Hisun Pharmaceuticals USA Inc.
6 drugs in NADAC|6 Generic,0 Brand
Hisun Pharmaceuticals USA Inc. lists 6 NDCs in the CMS NADAC file (6 generic, 0 brand), at an average NADAC of $1.60 per unit, with a week-over-week move of -1.2% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
6
6G / 0B
Avg Price / Unit
$1.5957
$0.11 – $8.48
Avg 7d Change
-1.17%
Across 4 drugs with changes
7d Activity
of 6 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
IRBESARTAN market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Angiotensin 2 Receptor Blocker therapeutic class
Review the broader class where Hisun Pharmaceuticals USA Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Hisun Pharmaceuticals USA Inc. make?
Hisun Pharmaceuticals USA Inc. lists 6 NDCs in the CMS NADAC file — 6 generic and 0 brand products.
What is the average price of Hisun Pharmaceuticals USA Inc. drugs?
The average NADAC across Hisun Pharmaceuticals USA Inc.'s portfolio is $1.5957 per unit, ranging from $0.1071 to $8.4839.
What types of drugs does Hisun Pharmaceuticals USA Inc. make?
Hisun Pharmaceuticals USA Inc. makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are Angiotensin 2 Receptor Blocker (4), Corticosteroid (1), P2Y12 Platelet Inhibitor (1).
Has Hisun Pharmaceuticals USA Inc. had any drug recalls?
No FDA enforcement recalls are matched to Hisun Pharmaceuticals USA Inc. in the openFDA feed.
How has Hisun Pharmaceuticals USA Inc.'s pricing changed recently?
Over the past 7 days, 1 Hisun Pharmaceuticals USA Inc. product rose and 3 fell, with a portfolio-wide average change of -1.2%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PREDNISOLONE 5 MG TABLET PREDNISOLONE | $8.4839 per EA | -1.51% |
IRBESARTAN 300 MG TABLET IRBESARTAN | $0.3342 per EA | — |
TICAGRELOR 90 MG TABLET Ticagrelor | $0.2529 per EA | -3.99% |
IRBESARTAN 150 MG TABLET IRBESARTAN | $0.2340 per EA | — |
IRBESARTAN 300 MG TABLET IRBESARTAN | $0.1623 per EA | +4.33% |
IRBESARTAN 150 MG TABLET IRBESARTAN | $0.1071 per EA | -3.50% |